These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21175237)

  • 1. Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?
    Sostres C; Lanas A
    Drugs; 2011 Jan; 71(1):1-10. PubMed ID: 21175237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
    Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
    Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
    Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
    Yang SC; Wu CK; Tai WC; Liang CM; Yao CC; Wu KL; Hsu CN; Chuah SK
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1828-1835. PubMed ID: 33247982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dilemma between gastroprotection and cardiovascular prevention].
    Venerito M; Kandulski A; Malfertheiner P
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
    J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.
    García-Rayado G; Sostres C; Lanas A
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):875-888. PubMed ID: 28463532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-platelet therapy and managing ulcer risk.
    Chan FK
    J Gastroenterol Hepatol; 2012 Feb; 27(2):195-9. PubMed ID: 22142030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial.
    Chiu PW; Joeng HK; Choi CL; Tsoi KK; Kwong KH; Lam SH; Sung JJ
    Endoscopy; 2016 Aug; 48(8):717-22. PubMed ID: 27275859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National consensus on management of peptic ulcer bleeding in Denmark 2014.
    Laursen SB; Jørgensen HS; Schaffalitzky de Muckadell OB;
    Dan Med J; 2014 Nov; 61(11):C4969. PubMed ID: 25370969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.
    Cryer B
    N Engl J Med; 2005 Jan; 352(3):287-9. PubMed ID: 15659730
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events.
    Sylvester KW; Cheng JW; Mehra MR
    Vasc Health Risk Manag; 2013; 9():245-54. PubMed ID: 23696706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.
    Goldstein JL; Whellan DJ; Scheiman JM; Cryer BL; Eisen GM; Lanas A; Fort JG
    Cardiovasc Ther; 2016 Apr; 34(2):59-66. PubMed ID: 26725920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.